Targeted Medical Pharma, Inc.
TRGM
Rank in Stocks
#35138
Targeted Medical Pharma, Inc., a specialty pharmaceutical company, doing... Targeted Medical Pharma, Inc., a specialty pharmaceutical company, doing business as Physician Therapeutics, develops and commercializes amino acid based medications to physicians, pharmacies, and patients in the United States. It offers a line of patented amino acid based medical food products, dietary supplements, and generic drugs primarily for the treatment of metabolic syndrome/obesity; sleep disorders associated with anxiety; hypertension; viral infections; cognitive disorders/fatigue; sleep disorders associated with depression, fibromyalgia, and PTSD; pain disorders and inflammatory conditions/fibromyalgia; osteoarthritis and joint disorders; and peripheral neuropathy. The company also provides a proprietary billing process and supporting software (PDRx) that facilitates physician dispensing; provides inventory control; and assists regulatory reporting. In addition, it offers billing and collection services relating to its products on behalf of dispensing physician clients to private insurance and workersโ compensation insurance. Targeted Medical Pharma, Inc. distributes its products through a network of distributors and an internal sales force that sells products directly to dispensing physician clients. The company was formerly known as Targeted Medical Foods and changed its name to Targeted Medical Pharma, Inc. in 2006. Targeted Medical Pharma, Inc. was founded in 1996 and is headquartered in Los Angeles, California.
Share Price
$0.00001
Last synced: 2026-11-10
Market Cap
$272.18
Change (1 day)
0.00%
Change (1 year)
-90.00%
Country
Stock data: Financial Modeling PrepยทUpdated ยทNot investment adviceยทHow we calculate this
Trade Targeted Medical Pharma, Inc. (TRGM)
Category
Healthcare
EPS for Targeted Medical Pharma, Inc. (TRGM)
EPS as of December 2015 TTM: $-0.11
According to Targeted Medical Pharma, Inc.'s latest financial reports, its current EPS (TTM) is $-0.11. At the end of 2015 the company had an EPS of $-0.11, an increase over its 2014 EPS of $-0.15.
EPS history for Targeted Medical Pharma, Inc. from 2008 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-0.11 | 0.00% |
| 2015 | $-0.11 | -26.67% |
| 2014 | $-0.15 | -61.54% |
| 2013 | $-0.39 | -9.30% |
| 2012 | $-0.43 | 126.32% |
| 2011 | $-0.19 | -226.67% |
| 2010 | $0.15 | -16.67% |
| 2009 | $0.18 | 20.00% |
| 2008 | $0.15 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $1.69 | -1,636.36% |
US
|
|
| $1.93 | -1,855.27% |
SE
|
|
| $6.91 | -6,385.45% |
FR
|
|
| $0.02 | -117.73% |
HK
|
|
| $2.71 | -2,563.45% |
IT
|
Questions about Targeted Medical Pharma, Inc.'s earnings per share (EPS)
What is Targeted Medical Pharma, Inc.'s earnings per share (EPS)?
Targeted Medical Pharma, Inc.'s earnings per share (EPS) over the last twelve months is $-0.11, as of Dec 2015.
What was Targeted Medical Pharma, Inc.'s earnings per share (EPS) in 2015?
In 2015, Targeted Medical Pharma, Inc.'s earnings per share (EPS) was $-0.11, compared with $-0.15 in 2014.
How has Targeted Medical Pharma, Inc.'s earnings per share (EPS) changed since 2010?
From 2010 to 2015, Targeted Medical Pharma, Inc.'s earnings per share (EPS) was highest in 2010 ($0.15) and lowest in 2012 ($-0.43).
How does Targeted Medical Pharma, Inc.'s earnings per share (EPS) compare with similar companies?
Targeted Medical Pharma, Inc.'s earnings per share (EPS) ($-0.11) is lower than that of all 5 similar companies listed above. The highest among them is Ipsen S.A., with $6.91.